does glp 1 cause gallstones FDA Data Link Diabetes Drug Class to Gallbladder Disease GLP-1 and Increased Incidence of

Liraglutide treatment enhanced the activity of group 3 innate lymphoid cells (ILC3s), leading to elevated levels of interleukin-22 (IL-22), a key cytokine essential for epithelial regeneration (86)

The straightforward answer is: maybe

In March 2024 the FDA approved semaglutide to help to lower the risk of cardiovascular death, heart attack and stroke in overweight or obese patients (Patchen)

Panacea was a Greek myth about curing everything

362 Although ferroptosis is not widely studied in the treatment of UC, it will certainly play a greater role in future research on the treatment of UC and the delay of disease progression

Manufacturer Pressure: Pharmaceutical manufacturers have aggressively sought to limit off-label and compounded distribution of GLP-1s, including through civil litigation, cease-and-desist letters, and collaboration with regulators